Growth Metrics

Nexalin Technology (NXL) Interest Expenses (2021 - 2026)

Nexalin Technology's quarterly Interest Expenses came in at -$34.0 in Q1 2026, up 96.92% year-on-year from -$17.27 in Q1 2025, and up 78.62% quarter-over-quarter from -$159.0 in Q4 2025.

Nexalin Technology has reported Interest Expenses for 6 years, with the latest figure at -$34.0 in Q1 2026.

  • For the quarter ending Q1 2026, Interest Expenses rose 96.92% year-over-year to -$34.0; the trailing twelve-month figure through Mar 2026 stood at -$7171.0 (down 79.63% YoY), and the FY2025 full-year result was -$8240.0, down 158.06% from the prior year.
  • Interest Expenses for Q1 2026 stood at -$34.0, up from -$159.0 in the prior quarter.
  • The five-year high for Interest Expenses was $19150.0 in Q4 2023, with the low at -$4690.0 in Q2 2025.
  • Average Interest Expenses over 5 years is $4340.5, with a median of -$50.0 recorded in 2024.
  • Year-over-year, Interest Expenses plunged 7006.06% in 2025 and jumped 96.92% in 2026.
  • Tracing NXL's Interest Expenses over 5 years: stood at $13496.0 in 2022, then jumped by 41.89% to $19150.0 in 2023, then slumped by 109.52% to -$1823.0 in 2024, then jumped by 91.28% to -$159.0 in 2025, then surged by 78.62% to -$34.0 in 2026.
  • The last three Interest Expenses figures came in at -$34.0 (Q1 2026), -$159.0 (Q4 2025), and -$2288.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 174.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 148.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 181.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 90.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -97.17 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 96.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.10 Mn
10 Nexalin Technology 11.19 Mn 8.48 Mn 13,133.00 -34.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -34.00
Mar 31, 2026 -34.00
Dec 31, 2025 -159.00
Dec 31, 2025 -159.00
Sep 30, 2025 -2,288.00
Sep 30, 2025 -2,288.00
Jun 30, 2025 -4,690.00
Jun 30, 2025 -4,690.00
Mar 31, 2025 -1,103.00
Mar 31, 2025 -1,103.00
Dec 31, 2024 -1,823.00
Dec 31, 2024 -1,823.00
Sep 30, 2024 -1,000.00
Sep 30, 2024 -1,000.00
Jun 30, 2024 -66.00
Jun 30, 2024 -66.00
Mar 31, 2024 -304.00
Mar 31, 2024 -304.00
Dec 31, 2023 19,150.00
Dec 31, 2023 19,150.00
Sep 30, 2023 5,330.00
Sep 30, 2023 5,330.00
Jun 30, 2023 5,518.00
Jun 30, 2023 5,518.00
Mar 31, 2023 8,837.00
Mar 31, 2023 8,837.00
Dec 31, 2022 13,496.00
Dec 31, 2022 13,496.00
Sep 30, 2022 10,452.00
Sep 30, 2022 10,452.00
Mar 31, 2022 18,132.00
Mar 31, 2022 18,132.00
Dec 31, 2021 18,439.00
Dec 31, 2021 18,439.00
Sep 30, 2021 27,175.00
Sep 30, 2021 27,175.00